Anuh Pharma Limited (BOM:506260)
81.24
+1.65 (2.07%)
At close: Sep 4, 2026
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 8.14 billion as of September 4, 2026. Its market cap has decreased by -5.94% in one year.
Market Cap
8.14B
Enterprise Value
7.61B
Revenue
7.79B
Ranking
n/a
PE Ratio
18.44
Stock Price
81.24
ChartMarket Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 8.14B, an increase of 3,610.33%. That is a compound annual growth rate of 21.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 8.14B | 0.94% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 14.64B |
| Fermenta Biotech | 14.29B |
| Lincoln Pharmaceuticals | 12.39B |
| Kopran | 11.24B |
| Bharat Parenterals | 10.53B |
| Sudarshan Pharma Industries | 9.49B |
| Wanbury | 8.60B |
| ZIM Laboratories | 6.72B |